Clinical trial

Pediatric ADVAIR DISKUS Versus Oral Montelukast Chewable Tablets

NCT00328718

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2005-10-01

PhasePHASE3

Study timeline

Study start (actual)2005-10-01Date precision: month

Registry last updated2017-01-20

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Asthmaunresolved

Interventions

montelukast (5mg QD)DRUG

Salmeterol/Fluticasone propionate Inhalation Powder (50/100mcg BID)DRUG

Sponsors & collaborators

GlaxoSmithKlinelead sponsor

Mapped research locations

IstanbulTurkey (Türkiye)2 Mexico CityMexico2 Buenos AiresArgentina1 AnkaraTurkey (Türkiye)1 IzmirTurkey (Türkiye)1 GuadalajaraJalisco, Mexico1 MonterreyNuevo León, Mexico1 AdanaTurkey (Türkiye)1 BogotáColombia1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00328718 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.